Evidence map›Paper›PMID 29469905›Full record

ArticleHeart Asia2017

Predictors of cardiac benefits of renal artery stenting from a multicentre retrospective registry.

Yuri Nakajima, Osami Kawarada, Akihiro Higashimori, Yoshiaki Yokoi, Kan Zen, Hitoshi Anzai, Hideki Doi, Seiji Hokimoto, Shigenori Ito, Taku Kato and 7 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart Asia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 1 country.

Yuri NakajimaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Osami KawaradaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Akihiro HigashimoriDepartment of Cardiology, Kishiwada Tokushukai Hospital, Osaka, Japan.
Yoshiaki YokoiDepartment of Cardiology, Kishiwada Tokushukai Hospital, Osaka, Japan.
Kan ZenDepartment of Cardiology, Omihachiman Community Medical Center, Shiga, Japan.
Hitoshi AnzaiDepartment of Cardiology, Ota Memorial Hospital, Gunma, Japan.
Hideki DoiDepartment of Cardiology, Kumamoto Rosai Hospital, Kumamoto, Japan.
Seiji HokimotoDepartment of Cardiology, Kumamoto University Hospital, Kumamoto, Japan.
Shigenori ItoDepartment of Cardiology, Nagoya City East Medical Center, Aichi, Japan.
Taku KatoDepartment of Cardiology, Nantan General Hospital, Kyoto, Japan.
Teruyoshi KumeDepartment of Cardiology, Kawasaki Medical School Hospital, Okayama, Japan.
Yoshiaki ShintaniDepartment of Cardiology, Shin Koga Hospital, Fukuoka, Japan.
Shuzou TanimotoDepartment of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Yoshinori TsubakimotoDepartment of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Makoto UtsunomiyaDepartment of Cardiology, Tokyo Rosai Hospital, Tokyo, Japan.
Kunihiro NishimuraDepartment of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Osaka, Japan.
Satoshi YasudaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kishiwada Tokushukai Hospital · JPNational Cerebral and Cardiovascular Center · JPFuji Heavy Industries Health Insurance Society Ota Memorial Hospital · JPKawasaki Medical School Hospital · JPKoga Hospital · JPKumamotorosaibyoin · JPKumamoto University Hospital · JPKyoto first Red Cross hospital · JPMitsui Memorial Hospital · JPNagoya Medical Center · JPNantan General Hospital · JPTokyo Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere have been limited data regarding the prediction of cardiac benefits after renal artery stenting for patients with atherosclerotic renal artery disease (ARAD). The aim of this multicentre retrospective study was to identify clinical or echocardiographic factors associated with improvements of cardiac symptoms after renal artery stenting.

methodsWe enrolled 58 patients with de novo ARAD undergoing successful renal artery stenting for heart failure, angina or both between January 2000 and August 2015 at 13 hospitals.

resultsImprovement of cardiac symptoms was observed in 86.2% of patients during a mean follow-up of 6.0±2.7 months. Responders demonstrated significantly lower New York Heart Association functional class, higher estimated glomerular filtration rate, lower serum creatinine and lower interventricular septal wall thickness (IVS), lower left ventricular mass index, lower left atrial dimension and lower E-velocity than non-responders. Backward stepwise multivariate analysis identified IVS as an independent predictor of improvement of cardiac symptoms (OR 0.451, 95% CI 0.209 to 0.976; p=0.043). According to receiver operating characteristic curve analysis, an IVS cut-off of 11.9 mm provided the best predictive value, with sensitivity of 71.4%, specificity of 75.5% and accuracy of 73.5%. The positive predictive value was 74.5% and the negative predictive value was 72.5%.

conclusionsThis multicentre retrospective study shows that the echocardiographic index of IVS is an independent predictor for improvement of cardiac symptoms after renal artery stenting.

Identifiers

PMID29469905
PMCPMC5818039
OpenAlexW2755701438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.